StockIQ.techAlign Technology, Inc. (ALGN) Stock Analysis
Free AI-powered analysis and research for Align Technology, Inc. stock
Sector: Healthcare
ALGN snapshot
Data as of 3 Nov 2026 close. Updated daily.
Align Technology, Inc. scores 65/100 on StockIQ's model, which reads as positive signals overall. The price is below its 200-day average and at 32% of its 52-week range, up 10.2% over the past year. Latest reported figures show a profit margin of 10.0%, return on equity of 10.2% and revenue growth of +4.3%.
What is driving the score
- RSI Neutral: +5
- Uptrend: +3
- MACD Bullish: +8
- Low Debt (0.03 D/E): +8
- Weak Liquidity (1.40 Current Ratio): -5
- Below MA200: -4
- Up Over 1 Year (+10.2%): +3
- Low Volume (0.2x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full ALGN report
Align Technology, Inc. (ALGN) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ALGN Now →📰 Latest Update
Align Technology Opens 2027 Annual Research Program to Advance Orthodontic and Dental Patient Care
Mon, November 2, 2026 at 9:00 PM UTC 2 min read
Align Technology, Inc. (NASDAQ: ALGN) has launched its 2027 Annual Research Award Program, offering up to $300,000 in funding to support clinical and scientific dental research at universities worldwide. Since its inception in 2010, the program has funded approximately $4.16 million in research aimed at advancing patient care in orthodontics and dentistry. Applications for the awards are open until March 5, 2027, with recipients to be notified by June 7, 2027.